{"&cites=15395269718627030077&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Frequent pathway mutations of splicing machinery in myelodysplasia","url":"https://www.nature.com/articles/nature10496?page=41","authors":["K Yoshida","K Yoshida M Sanada","K Yoshida M Sanada Y Shiraishi","K Yoshida M Sanada Y Shiraishi D Nowak","K Yoshida M Sanada Y Shiraishi D Nowak Y Nagata…"],"year":2011,"numCitations":1614,"pdf":"http://www.academia.edu/download/40102532/Frequent_pathway_mutations_of_splicing_m20151117-24458-1ri59nh.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13702732177642209520&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:8MCtvFDiKb4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13702732177642209520&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com","p":1,"exp":1596881701026},{"title":"Clinical effect of point mutations in myelodysplastic syndromes","url":"https://www.nejm.org/doi/full/10.1056/Nejmoa1013343","authors":["R Bejar","R Bejar K Stevenson","R Bejar K Stevenson O Abdel"],"year":2011,"numCitations":1354,"pdf":"https://www.nejm.org/doi/full/10.1056/Nejmoa1013343","citationUrl":"http://scholar.google.com/scholar?cites=9673082386904433203&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:M8KGQi6xPYYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9673082386904433203&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","url":"https://www.nature.com/ng/journal/v41/n7/full/ng.391.html","authors":["SMC Langemeijer","SMC Langemeijer RP Kuiper","SMC Langemeijer RP Kuiper M Berends","SMC Langemeijer RP Kuiper M Berends R Knops…"],"year":2009,"numCitations":777,"pdf":"https://www.researchgate.net/profile/Anne_Hagemeijer/publication/26254567_Acquired_mutations_in_TET2_are_common_in_myelodysplastic_syndromes/links/02e7e533d3f66a90f9000000/Acquired-mutations-in-TET2-are-common-in-myelodysplastic-syndromes.pdf","citationUrl":"http://scholar.google.com/scholar?cites=9154799354225260511&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:33eSKoJhDH8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9154799354225260511&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","url":"https://www.nature.com/articles/ng.620?page=21","authors":["G Nikoloski","G Nikoloski SMC Langemeijer","G Nikoloski SMC Langemeijer RP Kuiper","G Nikoloski SMC Langemeijer RP Kuiper R Knops…"],"year":2010,"numCitations":717,"pdf":"http://fulltext.calis.edu.cn/nature/ng/42/8/ng.620.pdf","citationUrl":"http://scholar.google.com/scholar?cites=13436763661865516896&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:YP9eBFz5eLoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13436763661865516896&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Myelodysplastic syndromes","url":"https://www.nejm.org/doi/full/10.1056/NEJMra0902908","authors":["A Tefferi","A Tefferi JW Vardiman"],"year":2009,"numCitations":680,"pdf":"http://www.christimres.com/uploads/7/0/7/6/70764707/myelodysplastic_syndromes.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11840722269919150917&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:RYOWbiuyUqQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11840722269919150917&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived …","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4874200/","authors":["J Schanz","J Schanz H Tüchler","J Schanz H Tüchler F Solé","J Schanz H Tüchler F Solé M Mallo…"],"year":2012,"numCitations":590,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc4874200/","citationUrl":"http://scholar.google.com/scholar?cites=3694515211590319990&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:dj8etAKORTMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3694515211590319990&hl=en&as_sdt=2005&sciodt=0,5","publication":"ncbi.nlm.nih.gov"},{"title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","url":"https://ashpublications.org/blood/article-abstract/122/17/2943/31935","authors":["L Malcovati","L Malcovati E Hellström"],"year":2013,"numCitations":516,"pdf":"https://ashpublications.org/blood/article-lookup/doi/10.1182/blood-2013-03-492884","citationUrl":"http://scholar.google.com/scholar?cites=10952127596705054304&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:YH5buAXG_ZcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10952127596705054304&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"},{"title":"Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms","url":"https://www.nature.com/articles/nature08240","authors":["M Sanada","M Sanada T Suzuki","M Sanada T Suzuki LY Shih","M Sanada T Suzuki LY Shih M Otsu","M Sanada T Suzuki LY Shih M Otsu M Kato…"],"year":2009,"numCitations":418,"pdf":"https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/192124/1/digar02085.pdf","citationUrl":"http://scholar.google.com/scholar?cites=9765315800211158370&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:YnUYP_tehYcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9765315800211158370&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms","url":"https://ashpublications.org/blood/article-abstract/118/24/6239/29197","authors":["L Malcovati","L Malcovati E Papaemmanuil…"],"year":2011,"numCitations":415,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236114/","citationUrl":"http://scholar.google.com/scholar?cites=499365036043216883&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:8yebwtoZ7gYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=499365036043216883&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"},{"title":"A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with …","url":"https://ashpublications.org/blood/article-abstract/118/14/3765/28713","authors":["P Fenaux","P Fenaux A Giagounidis","P Fenaux A Giagounidis D Selleslag","P Fenaux A Giagounidis D Selleslag O Beyne"],"year":2011,"numCitations":398,"pdf":"https://www.researchgate.net/profile/Guillermo_Sanz/publication/51489546_A_randomized_phase_3_study_of_lenalidomide_versus_placebo_in_RBC_transfusion-dependent_patients_with_Low-Intermediate-1-risk_myelodysplastic_syndromes_with_del5q/links/5640b08008ae24cd3e4090d2.pdf","citationUrl":"http://scholar.google.com/scholar?cites=12182646009083211070&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Pi28s_9zEakJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12182646009083211070&hl=en&as_sdt=2005&sciodt=0,5","publication":"ashpublications.org"}]}